Telix Pharmaceuticals Limited is a clinical-stage biotechnology company dedicated to the development and commercialisation of molecularly-targeted radiation (MTR) therapy. Our products seek to address major clinical unmet needs in the management of prostate, renal (kidney) and glioblastoma (brain) cancer.
Our mission is
to help patients
with cancer live longer
with better quality lives
Calling 4 a Clinical Research Coordinator in Nuclear Medicine / Theranostics @ Peter Mac: outstanding opportunity to be involved in clinical research in a stimulating work environment. Follow link for more info. https://t.co/3WdWcPw1Wx